Cargando…

An economic model of long-term use of celecoxib in patients with osteoarthritis

BACKGROUND: Previous evaluations of the cost-effectiveness of the cyclooxygenase-2 selective inhibitor celecoxib (Celebrex, Pfizer Inc, USA) have produced conflicting results. The recent controversy over the cardiovascular (CV) risks of rofecoxib and other coxibs has renewed interest in the economic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loyd, Michael, Rublee, Dale, Jacobs, Philip
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1925103/ https://www.ncbi.nlm.nih.gov/pubmed/17610716 http://dx.doi.org/10.1186/1471-230X-7-25

Ejemplares similares

The economic and clinical burden of early versus late initiation of celecoxib among patients with osteoarthritis
por: Shelbaya, Ahmed, et al.
Publicado: (2018)

Economic Outcomes Related to Persistence and Dosing of Celecoxib in Patients with Osteoarthritis (OA) Using a Retrospective Claims Database Analysis
por: Johnson, Courtney, et al.
Publicado: (2020)

Efficacy of Intra-Articular Injection of Celecoxib in a Rabbit Model of Osteoarthritis
por: Jiang, Dinghua, et al.
Publicado: (2010)

A comparative study of the efficacy of NAXOZOL compared to celecoxib in patients with osteoarthritis
por: Park, Moon Soo, et al.
Publicado: (2020)

Efficacy and tolerability of celecoxib and naproxen versus placebo in Hispanic patients with knee osteoarthritis
por: Essex, Margaret Noyes, et al.
Publicado: (2014)

Meta-analysis Comparing Celecoxib with Diclofenac Sodium in Patients with Knee Osteoarthritis
por: Huang, Hetao, et al.
Publicado: (2020)

Controlled release of celecoxib inhibits inflammation, bone cysts and osteophyte formation in a preclinical model of osteoarthritis
por: Tellegen, A. R., et al.
Publicado: (2018)

Cardiovascular safety of celecoxib in rheumatoid arthritis and osteoarthritis patients: A systematic review and meta-analysis
por: Cheng, Bai-Ru, et al.
Publicado: (2021)

Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis
por: Zweers, Manon C, et al.
Publicado: (2011)

Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: A randomised controlled trial in patients with osteoarthritis
por: Fleischmann, Roy, et al.
Publicado: (2008)

Preoperative celecoxib analgesia is more efficient and equally tolerated compared to postoperative celecoxib analgesia in knee osteoarthritis patients undergoing total knee arthroplasty: A randomized, controlled study
por: Liu, Jiangfeng, et al.
Publicado: (2018)

Effectiveness and safety of Glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee
por: Zeng, Chao, et al.
Publicado: (2015)

Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT)
por: Reginster, Jean-Yves, et al.
Publicado: (2017)

Evaluation of the Anti-Inflammatory and Chondroprotective Effect of Celecoxib on Cartilage Ex Vivo and in a Rat Osteoarthritis Model
por: Haartmans, Mirella J.J., et al.
Publicado: (2022)

Cytokinesis-block micronucleus assay of celecoxib and celecoxib derivatives
por: Reimann, Hauke, et al.
Publicado: (2020)

The effect of platelet rich plasma combined with celecoxib on knee function and pain in patients with knee osteoarthritis
por: Nie, Mingjun, et al.
Publicado: (2022)

Efficacy and Safety of Celecoxib Therapy in Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials
por: Xu, Chao, et al.
Publicado: (2016)

The cardiovascular risk of celecoxib for knee osteoarthritis: A protocol for systematic review and meta-analysis
por: Cheng, Shirui, et al.
Publicado: (2020)

Celecoxib vs diclofenac sodium in patients with knee osteoarthritis: A protocol for systematic review and meta analysis
por: Huang, Hetao, et al.
Publicado: (2020)

Celecoxib exhibits therapeutic potential in experimental model of hyperlipidaemia
por: Ekor, Martins, et al.
Publicado: (2021)

The association of comorbidities, utilization and costs for patients identified with low back pain
por: Ritzwoller, Debra P, et al.
Publicado: (2006)

Efficacy of celecoxib versus ibuprofen for the treatment of patients with osteoarthritis of the knee: A randomized double-blind, non-inferiority trial
por: Gordo, Ana C, et al.
Publicado: (2017)

Evaluating the Cost-Effectiveness of Celecoxib versus Ibuprofen and Naproxen in Patients with Osteoarthritis in United Arab Emirates Based on the PRECISION Trial
por: Chirikov, Viktor V, et al.
Publicado: (2021)

Anti-Psoriasis Effect of Diclofenac and Celecoxib Using the Tail Model for Psoriasis
por: Nițescu, Diana Ana-Maria, et al.
Publicado: (2022)

Efficacy of Etoricoxib, Celecoxib, Lumiracoxib, Non-Selective NSAIDs, and Acetaminophen in Osteoarthritis: A Mixed Treatment Comparison
por: Stam, WB, et al.
Publicado: (2012)

A Randomized, Multicenter, Phase III Trial to Evaluate the Efficacy and Safety of Polmacoxib Compared with Celecoxib and Placebo for Patients with Osteoarthritis
por: Lee, Myungchul, et al.
Publicado: (2017)

Reappraisal of the Therapeutic Role of Celecoxib in Cholangiocarcinoma
por: Yeh, Chun-Nan, et al.
Publicado: (2013)

Challenges and Opportunities for Celecoxib Repurposing
por: Bąk, Urszula, et al.
Publicado: (2023)

Preparation and Evaluation of Amino Acid Conjugates of Celecoxib as Prodrugs to Improve the Pharmacokinetic and Therapeutic Properties of Celecoxib
por: Lee, Yonghyun, et al.
Publicado: (2020)

Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib
por: Sobolewski, Cyril, et al.
Publicado: (2021)

Comparison between 200 mg QD and 100 mg BID oral celecoxib in the treatment of knee or hip osteoarthritis
por: Zeng, Chao, et al.
Publicado: (2015)

Combination of fasudil and celecoxib promotes the recovery of injured spinal cord in rats better than celecoxib or fasudil alone
por: Hou, Xiao-lin, et al.
Publicado: (2015)

The Efficacy of Continuous Versus Intermittent Celecoxib Treatment in Osteoarthritis Patients with Body Mass Index ≥30 and <30 kg/m(2)
por: Sands, George H, et al.
Publicado: (2013)

Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib
por: Hochberg, Marc C, et al.
Publicado: (2016)

S-Adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: A double-blind cross-over trial. [ISRCTN36233495]
por: Najm, Wadie I, et al.
Publicado: (2004)

Preventive but Not Curative Efficacy of Celecoxib on Bladder Carcinogenesis in a Rat Model
por: Sereno, José, et al.
Publicado: (2010)

Efficacy of Ciprofloxacin/Celecoxib combination in zebrafish models of amyotrophic lateral sclerosis
por: Goldshtein, Hagit, et al.
Publicado: (2020)

Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study
por: Pelletier, Jean-Pierre, et al.
Publicado: (2016)

Osteoarthritis- a systematic review of long-term safety implications for osteoarthritis of the knee
por: Charlesworth, Jonathon, et al.
Publicado: (2019)

Formulation and Evaluation of Liposomes for Transdermal Delivery of Celecoxib
por: Moghimipour, Eskandar, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0uk1gaeuuj744kerrb1a0f5jon